This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
SL Green (SLG) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Despite the negative impact of pandemic-induced job losses and remote-working dynamics, SL Green's (SLG) healthy leasing activities and portfolio occupancy in Q2 are likely to reflect recovery.
Telefonica (TEF) Boosts Debt Reduction Strategy With KKR Tie-Up
by Zacks Equity Research
Telefonica (TEF) partners with KKR to establish an independent wholesale fiber broadband network company in Colombia. The deal will also help in trimming Telefonica's heavy debt load.
What's in the Cards for Crown Castle (CCI) This Earnings Season?
by Zacks Equity Research
Solid carrier spending on networks and magnified focus on small-cell leasing are likely to have supported Crown Castle's (CCI) top-line growth during Q2.
Here's How Much You'd Have If You Invested $1000 in American Tower a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Here's How Much a $1000 Investment in American Tower Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
American Tower (AMT) Gains As Market Dips: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed at $269.51 in the latest trading session, marking a +1.12% move from the prior day.
American Tower (AMT) to Sell 10% in ATC Europe to Allianz Capital
by Zacks Equity Research
American Tower's (AMT) coalition with Allianz Capital will help in its European business expansion, in turn, generating sustainable growth and attractive returns in the years to come.
American Tower (AMT) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed the most recent trading day at $268.35, moving -0.91% from the previous trading session.
5 Stocks Set to Gain From the Ongoing 5G Boom
by Kaustav Ghosh
Watch out for names like Apple (AAPL), Corning (GLW), QUALCOMM (QCOM), American Tower (AMT) and Verizon (VZ) as factors like higher speed and lower latency boost demand for 5G.
American Tower (AMT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed at $265.28 in the latest trading session, marking a +0.73% move from the prior day.
American Tower (AMT) Closes Telxius Towers' Buyout in Europe
by Zacks Equity Research
The first tranche of Telxius Towers' buyout is likely to be immediately accretive for American Tower's (AMT) consolidated AFFO per share. Additional 4,000 sites in Germany are likely to close in Q3.
Telefonica (TEF) Sells Telxius' European Tower Division, Trims Debt
by Zacks Equity Research
Telefonica (TEF) displays operational strength with the completion of the sale of Telxius' mobile phone masts to American Tower Corporation (AMT) in Europe.
American Tower (AMT) Rewards Investors With 2.4% Dividend Hike
by Zacks Equity Research
American Tower's (AMT) recent dividend hike demonstrates the company's operational strength and commitment toward rewarding its shareholders handsomely.
American Tower (AMT) Boosts Flexibility With Notes Offering
by Zacks Equity Research
American Tower (AMT) plans to use the net proceeds for general corporate needs, including funding for acquisitions, additions to working capital and payback or refinancing of debt obligations.
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, CVS Health, American Tower Corp, The Southern Co, American International Group and Parker-Hannifin Corp
Top Stock Reports for Nike, CVS Health & American Tower
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), CVS Health Corporation (CVS), and American Tower Corporation (AMT).
American Tower (AMT) Q1 FFO Beat Estimates
by Zacks Equity Research
American Tower (AMT) delivered FFO and revenue surprises of 6.03% and -1.01%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
American Tower (AMT) Q1 AFFO Beats Estimates, Revenues Lag
by Zacks Equity Research
Strong organic tenant billing growth in Q1 supports American Tower's (AMT) Q1 results. However, a decline in revenues in the Asia Pacific property segment acts as a spoilsport.
Should You Buy American Tower (AMT) Ahead of Earnings?
by Zacks Equity Research
American Tower (AMT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
American Tower (AMT) Gains But Lags Market: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed at $254.04 in the latest trading session, marking a +0.99% move from the prior day.
How Will SBA Communications (SBAC) Fare in Q1 Earnings?
by Zacks Equity Research
Strength in site leasing, backed by aggressive network deployments by wireless carriers, is likely to have been a growth driver for SBA Communications (SBAC) in Q1.
American Tower (AMT) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
American Tower (AMT) closed the most recent trading day at $248.62, moving +0.59% from the previous trading session.
What's in the Cards for Crown Castle (CCI) in Q1 Earnings?
by Zacks Equity Research
Strong carrier spending on networks and focus on small-cell leasing are likely to have supported Crown Castle's (CCI) Q1 revenues.
American Tower (AMT) Up 6.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
American Tower (AMT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: UnitedHealth Group, Sony, American Tower, Advanced Micro Devices and Gilead Sciences
by Zacks Equity Research
The Zacks Analyst Blog Highlights: UnitedHealth Group, Sony, American Tower, Advanced Micro Devices and Gilead Sciences